Show notes
Thirty years ago children with Juvenile Idiopathic Arthritis (JIA) were at high risk of not only crippling physical disability, but also visual loss secondary to cataract, glaucoma and macular oedema caused by their chronic uveitis, or the steroids we used to treat it. Now, thanks to the development of targeted biological therapies, by clinical scientists like Andrew Dick, these children are living normal active lives and their risk of sight loss has been dramatically reduced.
In this episode of Eyes on Tomorrow we talk to Andrew about his career-long interest in immunology and inflammatory…
Website: eyesontomorrow.substack.com

